Skip to content

Does Prehabilitation Improve Exercise Performance and Insulin Resistance After Surgery for Oesophago-gastric Cancer?

Does Prehabilitation Improve Performance in Cardiopulmonary Exercise Testing and Reduce Insulin Resistance in Patients Undergoing Neo-adjuvant Treatment and Surgery for Oesophago-gastric Cancer?

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02950324
Enrollment
50
Registered
2016-11-01
Start date
2016-11-30
Completion date
2022-11-30
Last updated
2016-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Prehabilitation, Oesophago-gastric, Cancer, Neo-adjuvant, Exercise, Cardiopulmonary exercise test, Insulin resistance

Brief summary

The purpose of this study is to evaluate the effect of a multimodal pre-operative prehabilitation programme during neo-adjuvant therapy on cardiopulmonary exercise performance and insulin resistance prior to resection for oesophago-gastric cancer.

Detailed description

The trial objectives are as follows: Primary: To evaluate the effect of a prehabilitation programme during neo-adjuvant therapy on CPX performance prior to resection for oesophago-gastric cancer. Secondary: To investigate the impact of neo-adjuvant chemotherapy on insulin resistance; to determine whether a prehabilitation exercise programme is feasible during neo-adjuvant chemotherapy; to determine whether rehabilitation has a positive impact on quality of life outcomes; to investigate the impact of prehabilitation on clinical outcomes; to assess the effect of prehabilitation on nutritional status; to determine whether prehabilitation affects the stress response to surgery. This study is a randomised controlled trial where patients will be stratified into 'fit' and 'unfit' groups based upon their anaerobic threshold and then randomised in a 1:1 ratio to receive multimodal prehabilitation or standard care prior to OG cancer surgery, during neo-adjuvant chemotherapy.

Interventions

BEHAVIORALPrehabilitation

Patients in the intervention, 'Prehabilitation', arm of the study will be enrolled into a multimodal programme that involves 15 weeks of exercise, nutritional support and psychological prehabilitation in the form of 'Medical Coaching'. This will take place during neo-adjuvant treatment prior to oesophagectomy or gastrectomy for cancer.

BEHAVIORALStandard care

Patients in the 'standard care' arm of the study will not receive the study intervention. The patients will continue to be offered theatients in this arm of the study will not receive the study intervention. The patients will continue to be offered the standard dietetic and psychological support as per the enhanced recovery pathway and current standard of care standard dietetic and psychological support as per the enhanced recovery pathway and current standard of care.

Sponsors

Royal Surrey County Hospital NHS Foundation Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients listed for elective oesophagectomy or total gastrectomy for cancer * Must have capacity to consent * Age 18-99

Exclusion criteria

* Known contraindication for CPX * Physically unable to perform CPX test or undertake prehabilitation exercise programme * Pregnant patients or those planning to become pregnant * Lack of capacity to give informed consent

Design outcomes

Primary

MeasureTime frame
Change in cardiopulmonary exercise performanceChange in cardiopulmonary exercise performance between week 0 and week 17

Secondary

MeasureTime frame
Change in insulin resistanceChange in insulin resistance between week 0 and week 17
Change in quality of lifeChange in quality of life (as assessed by the EORTC QLQ C30 questionnaire) between week 0 and 6 months
Change in grip-strengthChange in grip-strength between 0 weeks and 6 months

Countries

United Kingdom

Contacts

Primary ContactSophie Allen, MBBCh
sophieallen@doctors.org.uk07733 258752
Backup ContactSarah Martin
sarah.martin33@nhs.net

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026